Safety and Efficacy of Velaglucerase Alfa in Patients with...

Molecular Genetics and Metabolism 2012 Vol. 105; Iss. 2

Safety and Efficacy of Velaglucerase Alfa in Patients with Type 1 Gaucher Disease: 2 Years of Treatment in Phase III Trials and an Extension Study

Ari Zimran, Madhulika Kabra, Pilar Giraldo, Marie-Françoise Ben Dridi, Deborah Elstein, Neerja Gupta, David Zahrieh, Eric Crombez, Hadhami Ben Turkia
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
105
Year:
2012
Language:
english
DOI:
10.1016/j.ymgme.2011.11.187
File:
PDF, 50 KB
english, 2012
Conversion to is in progress
Conversion to is failed